Are you looking to connect with others who have stage 3A NSCLC adenocarcinoma with negative biomarkers and are starting chemoradiation?
Stage 3 NSCLC involves various factors including tumor size, whether there's more than one tumor, spread to lymph nodes within the lung, and whether it has invaded other parts of the lung Show Full Answer
Are you looking to connect with others who have stage 3A NSCLC adenocarcinoma with negative biomarkers and are starting chemoradiation?
Stage 3 NSCLC involves various factors including tumor size, whether there's more than one tumor, spread to lymph nodes within the lung, and whether it has invaded other parts of the lung, chest wall, or surrounding organs. The cancer may have spread to lymph nodes within the lung or near the main airway.
Chemoradiation is a common treatment approach for stage 3 NSCLC when surgery isn't an option. This combination therapy uses chemotherapy and radiation together because the chemo helps make cancer cells more sensitive to radiation, which can make both treatments more effective.
Since your biomarkers are negative, targeted therapies that work on specific gene mutations (like EGFR or ALK inhibitors) wouldn't be part of your initial treatment plan. However, chemoradiation can still be very effective for stage 3 disease.
It's completely normal to want to hear from others in a similar situation as you prepare for treatment. Many members on MyLungCancerTeam share their experiences with chemoradiation and can offer support and practical tips for managing side effects.
November 10, 2025
Join
Your Privacy Choices
